These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38403681)

  • 1. Comprehensive Risk Assessment in Patients With Pulmonary Arterial Hypertension Referred for Lung Transplantation.
    Ishii S; Hatano M; Minatsuki S; Hirose K; Saito A; Yagi H; Shimbo M; Soma K; Konoeda C; Sato M; Nakajima J; Komuro I
    Circ J; 2024 Sep; 88(10):1610-1617. PubMed ID: 38403681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
    Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
    Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study).
    Lange TJ; Escribano-Subias P; Muller A; Fernandes CC; Fontana M; Remenova T; Söderberg S; Gaine S
    Adv Ther; 2024 Sep; 41(9):3645-3663. PubMed ID: 39083197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
    Boucly A; Beurnier A; Turquier S; Jevnikar M; de Groote P; Chaouat A; Cheron C; Jaïs X; Picard F; Prévot G; Roche A; Solinas S; Cottin V; Bauer F; Montani D; Humbert M; Savale L; Sitbon O;
    Eur Respir J; 2024 Sep; 64(3):. PubMed ID: 38663975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    Vicaire H; Pavec JL; Mercier O; Montani D; Boucly A; Roche A; Pradère P; Dauriat G; Feuillet S; Pichon J; Jevnikar M; Beurnier A; Jaïs X; Fadel E; Sitbon O; Humbert M; Savale L
    J Heart Lung Transplant; 2022 Sep; 41(9):1285-1293. PubMed ID: 35778258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Aug; 166(2):373-387. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.
    de Perrot M; Granton JT; McRae K; Pierre AF; Singer LG; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):910-8. PubMed ID: 22306224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension.
    Ishii S; Minatsuki S; Hatano M; Saito A; Yagi H; Shimbo M; Soma K; Fujiwara T; Itoh H; Konoeda C; Sato M; Takeda N; Daimon M; Nakajima J; Komuro I
    Sci Rep; 2023 Mar; 13(1):3758. PubMed ID: 36882461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation.
    Valdeolmillos E; Le Pavec J; Audié M; Savale L; Jais X; Montani D; Sitbon O; Feuillet S; Mercier O; Petit J; Humbert M; Fadel E; Belli E; Hascoët S
    J Thorac Cardiovasc Surg; 2024 Sep; 168(3):943-954. PubMed ID: 38052251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation effect of COMPERA 2.0 risk assessment model on prognosis of Chinese patients with pulmonary arterial hypertension].
    Liang YR; Yang YC; Yang BL; Zeng QX; Liu BY; Zhao Q; Luo Q; Zhao ZH; Yang T; Liu ZH; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1410-1416. PubMed ID: 37150694
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
    Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
    J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Celant LR; Wessels JN; Marcus JT; Meijboom LJ; Bogaard HJ; de Man FS; Vonk Noordegraaf A
    Chest; 2024 Jan; 165(1):181-191. PubMed ID: 37527773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Transplantation in Pulmonary Hypertension: A Multidisciplinary Unit's Management Experience.
    Quezada-Loaiza CA; de Pablo Gafas A; Pérez V; Alonso R; Juarros L; Real MI; López E; Cortes M; Meneses JC; González IH; Díaz-Hellín Gude V; Subías PE; Gámez P
    Transplant Proc; 2018 Jun; 50(5):1496-1503. PubMed ID: 29880377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension.
    Cruz-Utrilla A; Gallego-Zazo N; Pérez-Olivares C; Hernández-González I; Bedate P; Martínez Meñaca A; López Meseguer M; Lapunzina P; Pérez Núñez M; Ochoa Parra N; Valverde D; Tenorio-Castaño JA; Escribano-Subias P
    Rev Esp Cardiol (Engl Ed); 2023 Jun; 76(6):460-467. PubMed ID: 36403940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
    Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR
    Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
    Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.